tradingkey.logo
搜索

NeuroOne Medical Technologies Corp

NMTC
添加自选
3.000USD
-0.040-1.32%
收盘 07/01, 16:00美东报价延迟15分钟
25.85M总市值
亏损市盈率 TTM

NeuroOne Medical Technologies Corp

3.000
-0.040-1.32%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.32%

5天

-10.45%

1月

-15.49%

6月

-34.04%

今年开始到现在

-34.04%

1年

+342.28%

关键数据
3.050今开
3.138最高
19.01K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.22%换手率
3.040昨收
2.920最低
43.79K成交额
亏损市盈率静
4.81市净率
0.00%股息率 TTM
-107.84%ROA
6.96052周最高
0.48量比
-12.32M净利润
8.62M总股本
-2.9507每股收益TTM
0.53Beta
-204.44%ROE
3.27452周最低
7.16%振幅
53.81%毛利率
25.85M总市值
-3.21回报/风险
4.55%风险率

操作建议

NeuroOne Medical Technologies Corp当前公司基本面数据相对非常健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名106/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价9.93。中期看,股价处于下降通道。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

NeuroOne Medical Technologies Corp评分

相关信息

行业排名
106 / 204
全市场排名
247 / 4569
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

NeuroOne Medical Technologies Corp亮点

亮点风险
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
业绩高增长
公司营业收入稳步增长,连续3年增长250.82%
业绩增长期
公司处于发展阶段,最新年度总收入12.10M美元
估值高估
公司最新PE估值-1.03,处于3年历史高位
机构减仓
最新机构持股2.36M股,环比减少8.88%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00

分析师目标

根据 3 位分析师
买入
评级
9.933
目标均价
+226.75%
涨幅空间

NeuroOne Medical Technologies Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

NeuroOne Medical Technologies Corp简介

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
公司代码NMTC
公司NeuroOne Medical Technologies Corp
CEORosa (David A)
网址https://nmtc1.com/

常见问题

NeuroOne Medical Technologies Corp(NMTC)的当前股价是多少?

NeuroOne Medical Technologies Corp(NMTC)的当前股价是 3.04。

NeuroOne Medical Technologies Corp的股票代码是什么?

NeuroOne Medical Technologies Corp的股票代码是NMTC。

NeuroOne Medical Technologies Corp股票的52周最高点是多少?

NeuroOne Medical Technologies Corp股票的52周最高点是6.96。

NeuroOne Medical Technologies Corp股票的52周最低点是多少?

NeuroOne Medical Technologies Corp股票的52周最低点是3.27。

NeuroOne Medical Technologies Corp的市值是多少?

NeuroOne Medical Technologies Corp的市值是26.46M。

现在NeuroOne Medical Technologies Corp(NMTC)的股票是买入、持有还是卖出?

根据分析师评级,NeuroOne Medical Technologies Corp(NMTC)的总体评级为买入,目标价格为9.93。

NeuroOne Medical Technologies Corp(NMTC)股票的每股收益(EPS TTM)是多少

NeuroOne Medical Technologies Corp(NMTC)股票的每股收益(EPS TTM)是-0.54。